ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Contract Service Outsourcing Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-5F17094
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Contract Service Outsourcing Market Research Report 2024
BUY CHAPTERS

Global Pharmaceutical Contract Service Outsourcing Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-5F17094
Report
November 2025
Pages:147
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Charles River
IQVIA
Lonza
PPD
ICON
Inotiv, Inc.
LabCorp
Eurofins Scientific
JOINN Lab
Evotec AG
EVERSANA
Amplity Health
Tigermed
ChemPartner
Medicilon
WuXi AppTec
China Medical System
Sinco Pharma

Pharmaceutical Contract Service Outsourcing Market

The global Pharmaceutical Contract Service Outsourcing market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Pharmaceutical contract service outsourcing refers to a business model in which pharmaceutical companies entrust some non-core business functions or specific projects to external professional service providers for management and execution. These external service providers are typically specialized contract research organizations (CROs), contract manufacturing organizations (CMOs), contract sales organizations (CSOs) or other related service organizations.
From a downstream perspective, Pharmaceutical Company accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Pharmaceutical Contract Service Outsourcing leading manufacturers including Charles River, IQVIA, Lonza, PPD, ICON Plc, Inotiv, Labcorp, Eurofins Scientific, JOINN Lab, EVOTEC, etc., dominate supply; the top five capture approximately % of global revenue, with Charles River leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Pharmaceutical Contract Service Outsourcing market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Pharmaceutical Contract Service Outsourcing Market Report

Report Metric Details
Report Name Pharmaceutical Contract Service Outsourcing Market
Segment by Type
  • CRO
  • CMO
  • CDMO
  • CSO
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Charles River, IQVIA, Lonza, PPD, ICON Plc, Inotiv, Labcorp, Eurofins Scientific, JOINN Lab, EVOTEC, EVERSANA, Amplity Health, Tigermed, ChemPartner, Medicilon, WuXi AppTec, China Medical System, Sinco Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Pharmaceutical Contract Service Outsourcing study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Pharmaceutical Contract Service Outsourcing Market report?

Ans: The main players in the Pharmaceutical Contract Service Outsourcing Market are Charles River, IQVIA, Lonza, PPD, ICON Plc, Inotiv, Labcorp, Eurofins Scientific, JOINN Lab, EVOTEC, EVERSANA, Amplity Health, Tigermed, ChemPartner, Medicilon, WuXi AppTec, China Medical System, Sinco Pharma

What are the Application segmentation covered in the Pharmaceutical Contract Service Outsourcing Market report?

Ans: The Applications covered in the Pharmaceutical Contract Service Outsourcing Market report are Pharmaceutical Company, Biotechnology Company, Others

What are the Type segmentation covered in the Pharmaceutical Contract Service Outsourcing Market report?

Ans: The Types covered in the Pharmaceutical Contract Service Outsourcing Market report are CRO, CMO, CDMO, CSO

1 Study Coverage
1.1 Introduction to Pharmaceutical Contract Service Outsourcing: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Pharmaceutical Contract Service Outsourcing Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 CRO
1.2.3 CMO
1.2.4 CDMO
1.2.5 CSO
1.3 Market Segmentation by Application
1.3.1 Global Pharmaceutical Contract Service Outsourcing Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pharmaceutical Contract Service Outsourcing Revenue Estimates and Forecasts 2020-2031
2.2 Global Pharmaceutical Contract Service Outsourcing Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Pharmaceutical Contract Service Outsourcing Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Pharmaceutical Contract Service Outsourcing Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 CRO Market Size by Players
3.3.2 CMO Market Size by Players
3.3.3 CDMO Market Size by Players
3.3.4 CSO Market Size by Players
3.4 Global Pharmaceutical Contract Service Outsourcing Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Pharmaceutical Contract Service Outsourcing Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Pharmaceutical Contract Service Outsourcing Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Pharmaceutical Contract Service Outsourcing Market Size by Type (2020-2031)
6.4 North America Pharmaceutical Contract Service Outsourcing Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Pharmaceutical Contract Service Outsourcing Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Pharmaceutical Contract Service Outsourcing Market Size by Type (2020-2031)
7.4 Europe Pharmaceutical Contract Service Outsourcing Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Pharmaceutical Contract Service Outsourcing Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Size by Type (2020-2031)
8.4 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Pharmaceutical Contract Service Outsourcing Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Pharmaceutical Contract Service Outsourcing Market Size by Type (2020-2031)
9.4 Central and South America Pharmaceutical Contract Service Outsourcing Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Pharmaceutical Contract Service Outsourcing Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Pharmaceutical Contract Service Outsourcing Market Size by Type (2020-2031)
10.4 Middle East and Africa Pharmaceutical Contract Service Outsourcing Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Pharmaceutical Contract Service Outsourcing Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Charles River
11.1.1 Charles River Corporation Information
11.1.2 Charles River Business Overview
11.1.3 Charles River Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.1.4 Charles River Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.1.5 Charles River Pharmaceutical Contract Service Outsourcing Revenue by Product in 2024
11.1.6 Charles River Pharmaceutical Contract Service Outsourcing Revenue by Application in 2024
11.1.7 Charles River Pharmaceutical Contract Service Outsourcing Revenue by Geographic Area in 2024
11.1.8 Charles River Pharmaceutical Contract Service Outsourcing SWOT Analysis
11.1.9 Charles River Recent Developments
11.2 IQVIA
11.2.1 IQVIA Corporation Information
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.2.4 IQVIA Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.2.5 IQVIA Pharmaceutical Contract Service Outsourcing Revenue by Product in 2024
11.2.6 IQVIA Pharmaceutical Contract Service Outsourcing Revenue by Application in 2024
11.2.7 IQVIA Pharmaceutical Contract Service Outsourcing Revenue by Geographic Area in 2024
11.2.8 IQVIA Pharmaceutical Contract Service Outsourcing SWOT Analysis
11.2.9 IQVIA Recent Developments
11.3 Lonza
11.3.1 Lonza Corporation Information
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.3.4 Lonza Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.3.5 Lonza Pharmaceutical Contract Service Outsourcing Revenue by Product in 2024
11.3.6 Lonza Pharmaceutical Contract Service Outsourcing Revenue by Application in 2024
11.3.7 Lonza Pharmaceutical Contract Service Outsourcing Revenue by Geographic Area in 2024
11.3.8 Lonza Pharmaceutical Contract Service Outsourcing SWOT Analysis
11.3.9 Lonza Recent Developments
11.4 PPD
11.4.1 PPD Corporation Information
11.4.2 PPD Business Overview
11.4.3 PPD Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.4.4 PPD Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.4.5 PPD Pharmaceutical Contract Service Outsourcing Revenue by Product in 2024
11.4.6 PPD Pharmaceutical Contract Service Outsourcing Revenue by Application in 2024
11.4.7 PPD Pharmaceutical Contract Service Outsourcing Revenue by Geographic Area in 2024
11.4.8 PPD Pharmaceutical Contract Service Outsourcing SWOT Analysis
11.4.9 PPD Recent Developments
11.5 ICON Plc
11.5.1 ICON Plc Corporation Information
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.5.4 ICON Plc Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.5.5 ICON Plc Pharmaceutical Contract Service Outsourcing Revenue by Product in 2024
11.5.6 ICON Plc Pharmaceutical Contract Service Outsourcing Revenue by Application in 2024
11.5.7 ICON Plc Pharmaceutical Contract Service Outsourcing Revenue by Geographic Area in 2024
11.5.8 ICON Plc Pharmaceutical Contract Service Outsourcing SWOT Analysis
11.5.9 ICON Plc Recent Developments
11.6 Inotiv
11.6.1 Inotiv Corporation Information
11.6.2 Inotiv Business Overview
11.6.3 Inotiv Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.6.4 Inotiv Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.6.5 Inotiv Recent Developments
11.7 Labcorp
11.7.1 Labcorp Corporation Information
11.7.2 Labcorp Business Overview
11.7.3 Labcorp Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.7.4 Labcorp Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.7.5 Labcorp Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Corporation Information
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.8.4 Eurofins Scientific Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.8.5 Eurofins Scientific Recent Developments
11.9 JOINN Lab
11.9.1 JOINN Lab Corporation Information
11.9.2 JOINN Lab Business Overview
11.9.3 JOINN Lab Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.9.4 JOINN Lab Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.9.5 JOINN Lab Recent Developments
11.10 EVOTEC
11.10.1 EVOTEC Corporation Information
11.10.2 EVOTEC Business Overview
11.10.3 EVOTEC Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.10.4 EVOTEC Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 EVERSANA
11.11.1 EVERSANA Corporation Information
11.11.2 EVERSANA Business Overview
11.11.3 EVERSANA Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.11.4 EVERSANA Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.11.5 EVERSANA Recent Developments
11.12 Amplity Health
11.12.1 Amplity Health Corporation Information
11.12.2 Amplity Health Business Overview
11.12.3 Amplity Health Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.12.4 Amplity Health Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.12.5 Amplity Health Recent Developments
11.13 Tigermed
11.13.1 Tigermed Corporation Information
11.13.2 Tigermed Business Overview
11.13.3 Tigermed Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.13.4 Tigermed Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.13.5 Tigermed Recent Developments
11.14 ChemPartner
11.14.1 ChemPartner Corporation Information
11.14.2 ChemPartner Business Overview
11.14.3 ChemPartner Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.14.4 ChemPartner Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.14.5 ChemPartner Recent Developments
11.15 Medicilon
11.15.1 Medicilon Corporation Information
11.15.2 Medicilon Business Overview
11.15.3 Medicilon Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.15.4 Medicilon Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.15.5 Medicilon Recent Developments
11.16 WuXi AppTec
11.16.1 WuXi AppTec Corporation Information
11.16.2 WuXi AppTec Business Overview
11.16.3 WuXi AppTec Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.16.4 WuXi AppTec Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.16.5 WuXi AppTec Recent Developments
11.17 China Medical System
11.17.1 China Medical System Corporation Information
11.17.2 China Medical System Business Overview
11.17.3 China Medical System Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.17.4 China Medical System Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.17.5 China Medical System Recent Developments
11.18 Sinco Pharma
11.18.1 Sinco Pharma Corporation Information
11.18.2 Sinco Pharma Business Overview
11.18.3 Sinco Pharma Pharmaceutical Contract Service Outsourcing Product Features and Attributes
11.18.4 Sinco Pharma Pharmaceutical Contract Service Outsourcing Revenue and Gross Margin (2020-2025)
11.18.5 Sinco Pharma Recent Developments
12 Pharmaceutical Contract Service OutsourcingIndustry Chain Analysis
12.1 Pharmaceutical Contract Service Outsourcing Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Pharmaceutical Contract Service Outsourcing Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Pharmaceutical Contract Service Outsourcing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Charles River
IQVIA
Lonza
PPD
ICON
Inotiv, Inc.
LabCorp
Eurofins Scientific
JOINN Lab
Evotec AG
EVERSANA
Amplity Health
Tigermed
ChemPartner
Medicilon
WuXi AppTec
China Medical System
Sinco Pharma
List of Tables
 Table 1. Global Pharmaceutical Contract Service Outsourcing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Pharmaceutical Contract Service Outsourcing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Pharmaceutical Contract Service Outsourcing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Pharmaceutical Contract Service Outsourcing Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Pharmaceutical Contract Service Outsourcing Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Pharmaceutical Contract Service Outsourcing Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Pharmaceutical Contract Service Outsourcing Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Pharmaceutical Contract Service Outsourcing by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Service Outsourcing as of 2024)
 Table 11. Global Pharmaceutical Contract Service Outsourcing Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Pharmaceutical Contract Service Outsourcing Companies Headquarters
 Table 13. Global Pharmaceutical Contract Service Outsourcing Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Pharmaceutical Contract Service Outsourcing Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Pharmaceutical Contract Service Outsourcing Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Pharmaceutical Contract Service Outsourcing Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Pharmaceutical Contract Service Outsourcing Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Pharmaceutical Contract Service Outsourcing High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Pharmaceutical Contract Service Outsourcing Growth Accelerators and Market Barriers
 Table 25. North America Pharmaceutical Contract Service Outsourcing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Pharmaceutical Contract Service Outsourcing Growth Accelerators and Market Barriers
 Table 27. Europe Pharmaceutical Contract Service Outsourcing Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Pharmaceutical Contract Service Outsourcing Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Pharmaceutical Contract Service Outsourcing Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Pharmaceutical Contract Service Outsourcing Investment Opportunities and Key Challenges
 Table 31. Central and South America Pharmaceutical Contract Service Outsourcing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Pharmaceutical Contract Service Outsourcing Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Pharmaceutical Contract Service Outsourcing Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Charles River Corporation Information
 Table 35. Charles River Description and Major Businesses
 Table 36. Charles River Product Features and Attributes
 Table 37. Charles River Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Charles River Revenue Proportion by Product in 2024
 Table 39. Charles River Revenue Proportion by Application in 2024
 Table 40. Charles River Revenue Proportion by Geographic Area in 2024
 Table 41. Charles River Pharmaceutical Contract Service Outsourcing SWOT Analysis
 Table 42. Charles River Recent Developments
 Table 43. IQVIA Corporation Information
 Table 44. IQVIA Description and Major Businesses
 Table 45. IQVIA Product Features and Attributes
 Table 46. IQVIA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. IQVIA Revenue Proportion by Product in 2024
 Table 48. IQVIA Revenue Proportion by Application in 2024
 Table 49. IQVIA Revenue Proportion by Geographic Area in 2024
 Table 50. IQVIA Pharmaceutical Contract Service Outsourcing SWOT Analysis
 Table 51. IQVIA Recent Developments
 Table 52. Lonza Corporation Information
 Table 53. Lonza Description and Major Businesses
 Table 54. Lonza Product Features and Attributes
 Table 55. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Lonza Revenue Proportion by Product in 2024
 Table 57. Lonza Revenue Proportion by Application in 2024
 Table 58. Lonza Revenue Proportion by Geographic Area in 2024
 Table 59. Lonza Pharmaceutical Contract Service Outsourcing SWOT Analysis
 Table 60. Lonza Recent Developments
 Table 61. PPD Corporation Information
 Table 62. PPD Description and Major Businesses
 Table 63. PPD Product Features and Attributes
 Table 64. PPD Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. PPD Revenue Proportion by Product in 2024
 Table 66. PPD Revenue Proportion by Application in 2024
 Table 67. PPD Revenue Proportion by Geographic Area in 2024
 Table 68. PPD Pharmaceutical Contract Service Outsourcing SWOT Analysis
 Table 69. PPD Recent Developments
 Table 70. ICON Plc Corporation Information
 Table 71. ICON Plc Description and Major Businesses
 Table 72. ICON Plc Product Features and Attributes
 Table 73. ICON Plc Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. ICON Plc Revenue Proportion by Product in 2024
 Table 75. ICON Plc Revenue Proportion by Application in 2024
 Table 76. ICON Plc Revenue Proportion by Geographic Area in 2024
 Table 77. ICON Plc Pharmaceutical Contract Service Outsourcing SWOT Analysis
 Table 78. ICON Plc Recent Developments
 Table 79. Inotiv Corporation Information
 Table 80. Inotiv Description and Major Businesses
 Table 81. Inotiv Product Features and Attributes
 Table 82. Inotiv Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Inotiv Recent Developments
 Table 84. Labcorp Corporation Information
 Table 85. Labcorp Description and Major Businesses
 Table 86. Labcorp Product Features and Attributes
 Table 87. Labcorp Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Labcorp Recent Developments
 Table 89. Eurofins Scientific Corporation Information
 Table 90. Eurofins Scientific Description and Major Businesses
 Table 91. Eurofins Scientific Product Features and Attributes
 Table 92. Eurofins Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Eurofins Scientific Recent Developments
 Table 94. JOINN Lab Corporation Information
 Table 95. JOINN Lab Description and Major Businesses
 Table 96. JOINN Lab Product Features and Attributes
 Table 97. JOINN Lab Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. JOINN Lab Recent Developments
 Table 99. EVOTEC Corporation Information
 Table 100. EVOTEC Description and Major Businesses
 Table 101. EVOTEC Product Features and Attributes
 Table 102. EVOTEC Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. EVOTEC Recent Developments
 Table 104. EVERSANA Corporation Information
 Table 105. EVERSANA Description and Major Businesses
 Table 106. EVERSANA Product Features and Attributes
 Table 107. EVERSANA Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. EVERSANA Recent Developments
 Table 109. Amplity Health Corporation Information
 Table 110. Amplity Health Description and Major Businesses
 Table 111. Amplity Health Product Features and Attributes
 Table 112. Amplity Health Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Amplity Health Recent Developments
 Table 114. Tigermed Corporation Information
 Table 115. Tigermed Description and Major Businesses
 Table 116. Tigermed Product Features and Attributes
 Table 117. Tigermed Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Tigermed Recent Developments
 Table 119. ChemPartner Corporation Information
 Table 120. ChemPartner Description and Major Businesses
 Table 121. ChemPartner Product Features and Attributes
 Table 122. ChemPartner Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. ChemPartner Recent Developments
 Table 124. Medicilon Corporation Information
 Table 125. Medicilon Description and Major Businesses
 Table 126. Medicilon Product Features and Attributes
 Table 127. Medicilon Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. Medicilon Recent Developments
 Table 129. WuXi AppTec Corporation Information
 Table 130. WuXi AppTec Description and Major Businesses
 Table 131. WuXi AppTec Product Features and Attributes
 Table 132. WuXi AppTec Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 133. WuXi AppTec Recent Developments
 Table 134. China Medical System Corporation Information
 Table 135. China Medical System Description and Major Businesses
 Table 136. China Medical System Product Features and Attributes
 Table 137. China Medical System Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 138. China Medical System Recent Developments
 Table 139. Sinco Pharma Corporation Information
 Table 140. Sinco Pharma Description and Major Businesses
 Table 141. Sinco Pharma Product Features and Attributes
 Table 142. Sinco Pharma Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. Sinco Pharma Recent Developments
 Table 144. Raw Materials Key Suppliers
 Table 145. Distributors List
 Table 146. Market Trends and Market Evolution
 Table 147. Market Drivers and Opportunities
 Table 148. Market Challenges, Risks, and Restraints
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources


List of Figures
 Figure 1. Pharmaceutical Contract Service Outsourcing Product Picture
 Figure 2. Global Pharmaceutical Contract Service Outsourcing Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. CRO Product Picture
 Figure 4. CMO Product Picture
 Figure 5. CDMO Product Picture
 Figure 6. CSO Product Picture
 Figure 7. Global Pharmaceutical Contract Service Outsourcing Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Pharmaceutical Company
 Figure 9. Biotechnology Company
 Figure 10. Others
 Figure 11. Pharmaceutical Contract Service Outsourcing Report Years Considered
 Figure 12. Global Pharmaceutical Contract Service Outsourcing Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 14. Global Pharmaceutical Contract Service Outsourcing Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global Pharmaceutical Contract Service Outsourcing Revenue Market Share by Region (2020-2031)
 Figure 16. Global Pharmaceutical Contract Service Outsourcing Revenue Market Share Ranking (2024)
 Figure 17. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 18. CRO Revenue Market Share by Player in 2024
 Figure 19. CMO Revenue Market Share by Player in 2024
 Figure 20. CDMO Revenue Market Share by Player in 2024
 Figure 21. CSO Revenue Market Share by Player in 2024
 Figure 22. Global Pharmaceutical Contract Service Outsourcing Revenue Market Share by Type (2020-2031)
 Figure 23. Global Pharmaceutical Contract Service Outsourcing Revenue Market Share by Application (2020-2031)
 Figure 24. North America Pharmaceutical Contract Service Outsourcing Revenue YoY (2020-2031) & (US$ Million)
 Figure 25. North America Top 5 Players Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) in 2024
 Figure 26. North America Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Type (2020 - 2031)
 Figure 27. North America Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Application (2020-2031)
 Figure 28. US Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 29. Canada Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 30. Mexico Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 31. Europe Pharmaceutical Contract Service Outsourcing Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. Europe Top 5 Players Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) in 2024
 Figure 33. Europe Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Type (2020-2031)
 Figure 34. Europe Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Application (2020-2031)
 Figure 35. Germany Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 36. France Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 37. U.K. Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 38. Italy Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 39. Russia Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Pharmaceutical Contract Service Outsourcing Revenue YoY (2020-2031) & (US$ Million)
 Figure 41. Asia-Pacific Top 8 Players Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) in 2024
 Figure 42. Asia-Pacific Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Asia-Pacific Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Indonesia Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 45. Japan Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 46. South Korea Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 47. Australia Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 48. India Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 49. Indonesia Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 50. Vietnam Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 51. Malaysia Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 52. Philippines Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 53. Singapore Pharmaceutical Contract Service Outsourcing Revenue (2020-2031) & (US$ Million)
 Figure 54. Central and South America Pharmaceutical Contract Service Outsourcing Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Central and South America Top 5 Players Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) in 2024
 Figure 56. Central and South America Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Type (2020-2031)
 Figure 57. Central and South America Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Application (2020-2031)
 Figure 58. Brazil Pharmaceutical Contract Service Outsourcing Revenue (2020-2025) & (US$ Million)
 Figure 59. Argentina Pharmaceutical Contract Service Outsourcing Revenue (2020-2025) & (US$ Million)
 Figure 60. Middle East and Africa Pharmaceutical Contract Service Outsourcing Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Middle East and Africa Top 5 Players Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) in 2024
 Figure 62. South America Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Type (2020-2031)
 Figure 63. Middle East and Africa Pharmaceutical Contract Service Outsourcing Revenue (US$ Million) by Application (2020-2031)
 Figure 64. GCC Countries Pharmaceutical Contract Service Outsourcing Revenue (2020-2025) & (US$ Million)
 Figure 65. Israel Pharmaceutical Contract Service Outsourcing Revenue (2020-2025) & (US$ Million)
 Figure 66. Egypt Pharmaceutical Contract Service Outsourcing Revenue (2020-2025) & (US$ Million)
 Figure 67. South Africa Pharmaceutical Contract Service Outsourcing Revenue (2020-2025) & (US$ Million)
 Figure 68. Pharmaceutical Contract Service Outsourcing Industry Chain Mapping
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Pharmaceutical CRO Services Market Research Report 2024
Global Pharmaceutical CMO Services Market Research Report 2024
Global Pharmaceutical Contract Sales Outsourcing CSO Market Research Report 2025
Pharmaceutical CXO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Contract Research Organisations CROs Market Research Report 2024
Global Biopharmaceutical CMO Services Market Research Report 2024
Global Clinical Contract Research Organization Services Market Research Report 2024
Global Pharmaceutical R D Outsourcing Services CRO Market Research Report 2024
Global Pharmaceutical Contract Sales Organization CSO Market Research Report 2025
Global Pharmaceutical Products and CMO Market Research Report 2024
Global Clinical and Non clinical Contract Research Organization Services Market Research Report 2024
Pharmaceutical Contract Manufacturing and Contract Market
Global Contract Pharmaceutical Manufacturing Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Contract Research Organizations Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Outsourcing in Drug Discovery Market Research Report 2024
Healthcare Contract Development And Manufacturing Organization Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
CROs Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRO Services Market Research Report 2024
Global The Contract Research CRO Market Insights Forecast to 2030
Global Medical CXO Services Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions